PE20121501A1 - Proceso para la elaboracion de compuestos organicos - Google Patents

Proceso para la elaboracion de compuestos organicos

Info

Publication number
PE20121501A1
PE20121501A1 PE2012000559A PE2012000559A PE20121501A1 PE 20121501 A1 PE20121501 A1 PE 20121501A1 PE 2012000559 A PE2012000559 A PE 2012000559A PE 2012000559 A PE2012000559 A PE 2012000559A PE 20121501 A1 PE20121501 A1 PE 20121501A1
Authority
PE
Peru
Prior art keywords
alkyl
elaboration
compound
formula
organic compounds
Prior art date
Application number
PE2012000559A
Other languages
English (en)
Inventor
Gottfried Sedelmeier
Florian Andreas Rampf
Dominique Grimler
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41716392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20121501(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20121501A1 publication Critical patent/PE20121501A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C07C253/34—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A UN PROCESO PARA LA ELABORACION DE UN COMPUESTO DE FORMULA (IV) QUE COMPRENDE: A) HACER REACCIONAR EL COMPUESTO DE FORMULA (III) DONDE R ES ALQUILO C1-7, (*), ENTRE OTROS; R1 ES H, ALQUILO C1-7, ALCOXILO C1-7, CICLOALQUILO C3-8, ENTRE OTROS; R2 ES H, HALOGENO, NITRO, ALQUILO C1-7, ENTRE OTROS, B) CON HALURO DE ORGANOALUMINIO DE FORMULA R5R6AlX O R5AlX2, DONDE R5 Y R6 SON INDEPENDIENTEMENTE ALQUILO C1-7, ALQUENILO C3-8, CICLOALQUILO C3-8, ENTRE OTROS; X ES HALOGENO. DICHO COMPUESTO ES UN ANTAGONISTA DE LOS RECEPTORES DE ANGIOTENSINA II, SIENDO UTIL PARA EL TRATAMIENTO DE HIPERTENSION
PE2012000559A 2009-10-27 2010-10-25 Proceso para la elaboracion de compuestos organicos PE20121501A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09174264A EP2316821A1 (en) 2009-10-27 2009-10-27 Process for the manufacture of organic compounds

Publications (1)

Publication Number Publication Date
PE20121501A1 true PE20121501A1 (es) 2012-11-15

Family

ID=41716392

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000559A PE20121501A1 (es) 2009-10-27 2010-10-25 Proceso para la elaboracion de compuestos organicos

Country Status (23)

Country Link
US (1) US20120238761A1 (es)
EP (2) EP2316821A1 (es)
JP (1) JP2013508436A (es)
KR (1) KR20120098652A (es)
CN (1) CN102596899A (es)
AR (1) AR079104A1 (es)
AU (1) AU2010311636B2 (es)
BR (1) BR112012009815A2 (es)
CA (1) CA2777031A1 (es)
CL (1) CL2012001081A1 (es)
CO (1) CO6531487A2 (es)
EC (1) ECSP12011833A (es)
IL (1) IL219111A0 (es)
IN (1) IN2012DN03032A (es)
MA (1) MA33692B1 (es)
MX (1) MX2012005025A (es)
NZ (1) NZ599218A (es)
PE (1) PE20121501A1 (es)
RU (1) RU2012121591A (es)
TN (1) TN2012000154A1 (es)
TW (1) TW201124389A (es)
WO (1) WO2011051213A1 (es)
ZA (1) ZA201202490B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102321038B (zh) * 2011-07-11 2014-03-26 安徽省虹升生物科技有限公司 一种改进的制备缬沙坦方法
FR2981077B1 (fr) * 2011-10-11 2013-11-01 Michelin Soc Tech Methode pour preparer un melange maitre d'elastomere dienique et de silice
WO2018040065A1 (zh) * 2016-09-02 2018-03-08 诺瑞特国际药业股份有限公司 缬沙坦二钠盐的晶型
CN110078640B (zh) * 2019-03-29 2022-04-05 浙江美诺华药物化学有限公司 一种缬沙坦中间体的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874867A (en) 1987-05-22 1989-10-17 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
DE122007000050I1 (de) 1990-02-19 2007-11-08 Novartis Ag Acylverbindungen
JPH04297466A (ja) 1990-06-22 1992-10-21 Nippon Shinyaku Co Ltd テトラゾール誘導体及び医薬
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds
GB0222056D0 (en) 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
ITMI20032267A1 (it) 2003-11-21 2005-05-22 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procdimento per la preparzione di valsartan e suoi intermedi
HRP20030965A2 (en) * 2003-11-24 2005-08-31 Belupo - Lijekovi I Kozmetika D.D. Process for production of (s)-n-pentanoyl-n-[[2'-(
EP1714963A1 (en) * 2005-04-19 2006-10-25 IPCA Laboratories Limited Process for the Preparation of Valsartan and its Intermediates
ES2333169T3 (es) * 2005-08-22 2010-02-17 Alembic Limited Procedimiento para la preparacion de valsartan.
WO2008004110A2 (en) * 2006-07-03 2008-01-10 Aurobindo Pharma Limited Process for the preparation of the angiotensin ii antagonist valsartan
CN101450917B (zh) * 2007-12-06 2012-07-11 浙江海正药业股份有限公司 缬沙坦的合成方法
US7943794B2 (en) * 2008-02-13 2011-05-17 Ranbaxy Laboratories Limited Processes for the preparation of intermediates of valsartan

Also Published As

Publication number Publication date
TN2012000154A1 (en) 2013-12-12
MX2012005025A (es) 2012-06-08
US20120238761A1 (en) 2012-09-20
MA33692B1 (fr) 2012-10-01
BR112012009815A2 (pt) 2016-10-18
AU2010311636A1 (en) 2012-05-03
ZA201202490B (en) 2012-12-27
IN2012DN03032A (es) 2015-07-31
WO2011051213A1 (en) 2011-05-05
CA2777031A1 (en) 2011-05-05
JP2013508436A (ja) 2013-03-07
ECSP12011833A (es) 2012-06-29
RU2012121591A (ru) 2013-12-10
AU2010311636B2 (en) 2014-03-06
KR20120098652A (ko) 2012-09-05
EP2316821A1 (en) 2011-05-04
NZ599218A (en) 2014-02-28
TW201124389A (en) 2011-07-16
CN102596899A (zh) 2012-07-18
CL2012001081A1 (es) 2013-06-14
CO6531487A2 (es) 2012-09-28
IL219111A0 (en) 2012-06-28
AR079104A1 (es) 2011-12-28
EP2493848A1 (en) 2012-09-05

Similar Documents

Publication Publication Date Title
PE20070517A1 (es) Derivados de imidazol como agentes inhibidores de la sintasa de aldosterona y aromatasa
SV2009002876A (es) Derivados de triazol como inhibidores de 11-beta-hidroxiesteroide-deshidrogenasa-1
NI201000054A (es) Compuestos químicos.
MA32938B1 (fr) Composes organiques
PE20151537A1 (es) Bis(difluorometil)pirazoles como fungicidas
CR20120294A (es) Compuestos tricíclicos novedosos
ECSP088536A (es) DERIVADOS DE PIRIDO-, PIRAZO- Y PIRIMIDO-PIRIMIDINA COMO INHIBIDORES DE mTOR
CL2009001063A1 (es) Uso de una combinacion de un compuesto derivado de n-quinoliniloxifenil-n-fenilciclopropanodicarboxamida y un inhibidor de erbb seleccionado entre lapatinib, erlotinib, gefitinib, trastuzumab, cetuximab, para eltratamiento de canceres.
PE20150230A1 (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos
CR20120635A (es) Compuestos heterocìclicos de nitrògeno ùtiles como inhibidores de pde10
SV2010003617A (es) Fungicidas
CY1113131T1 (el) Τα παραγωγα ινδολης ως αγωνιστες υποδοχεων s1p1
PE20141678A1 (es) Indazol-3-carboxamidas y su uso como inhibidores de la ruta de senalizacion de wnt/b-catenina
ES2657549T3 (es) Piridopirazinas sustituidas como nuevos inhibidores de SYK
CO6561772A2 (es) Isoquinolinas y quinazolinonas sustituidas
PE20140858A1 (es) Derivados de piperidina como inhibidores de renina
MA32977B1 (fr) Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol
EA200900945A1 (ru) Новый способ синтеза агомелатина
PE20121501A1 (es) Proceso para la elaboracion de compuestos organicos
EA200900946A1 (ru) Новый способ синтеза агомелатина
PE20142281A1 (es) Compuestos de cromano sustituidos como moduladores del receptor sensible al calcio
PE20141579A1 (es) Nuevos 2h-indazoles como antagonistas del receptor ep2
EA201001882A1 (ru) Гидроксизамещенные тиенопиримидиноны как антагонисты рецептора-i меланинконцентрирующего гормона
UY31162A1 (es) Espiroindolinas como moduladores de receptores de quimioquinas
CU23853B1 (es) Pirimidinil-piperazinas útiles como ligandos del receptor d3/d2

Legal Events

Date Code Title Description
FA Abandonment or withdrawal